Answer
Lagevrio (molnupiravir) is contraindicated in people with hypersensitivity to molnupiravir or any of its excipients listed in section 6.1 of the product information.
Sources for this answer
- Lagevrio 200 mg hard capsulesMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.3 Contraindications · Version 11Document updated
Sources checked